Follow
Gopalakrishnan Bulusu
Gopalakrishnan Bulusu
Verified email at iiit.ac.in
Title
Cited by
Cited by
Year
Characterization of azithromycin hydrates
R Gandhi, O Pillai, R Thilagavathi, B Gopalakrishnan, CL Kaul, ...
European journal of pharmaceutical sciences 16 (3), 175-184, 2002
912002
A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models
B Gopalakrishnan, V Aparna, J Jeevan, M Ravi, GR Desiraju
Journal of chemical information and modeling 45 (4), 1101-1108, 2005
882005
PAT5A: a partial agonist of peroxisome proliferator-activated receptor γ is a potent antidiabetic thiazolidinedione yet weakly adipogenic
P Misra, R Chakrabarti, RK Vikramadithyan, G Bolusu, S Juluri, J Hiriyan, ...
Journal of Pharmacology and Experimental Therapeutics 306 (2), 763-771, 2003
882003
MD simulations of ligand-bound and ligand-free aptamer: molecular level insights into the binding and switching mechanism of the add A-riboswitch
M Sharma, G Bulusu, A Mitra
RNA 15 (9), 1673-1692, 2009
852009
Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1, 2 …
GR Desiraju, B Gopalakrishnan, RKR Jetti, A Nagaraju, D Raveendra, ...
Journal of medicinal chemistry 45 (22), 4847-4857, 2002
832002
Synthesis and cyclooxygenase-2 inhibiting property of 1, 5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: preparation of sodium salt for …
M Pal, M Madan, S Padakanti, VR Pattabiraman, S Kalleda, A Vanguri, ...
Journal of medicinal chemistry 46 (19), 3975-3984, 2003
722003
De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence
N Bung, SR Krishnan, G Bulusu, A Roy
Future medicinal chemistry 13 (06), 575-585, 2021
692021
3D-QSAR studies on thieno [3, 2-d] pyrimidines as phosphodiesterase IV inhibitors
AK Chakraborti, B Gopalakrishnan, ME Sobhia, A Malde
Bioorganic & medicinal chemistry letters 13 (8), 1403-1408, 2003
642003
Understanding the Thermostability and Activity of Bacillus subtilis Lipase Mutants: Insights from Molecular Dynamics Simulations
B Singh, G Bulusu, A Mitra
The Journal of Physical Chemistry B 119 (2), 392-409, 2015
622015
New styryl sulfones as anticancer agents
MS Vedula, AB Pulipaka, C Venna, VK Chintakunta, S Jennepalli, ...
European journal of medicinal chemistry 38 (9), 811-824, 2003
612003
Accelerating De Novo Drug Design against Novel Proteins Using Deep Learning
SR Krishnan, N Bung, G Bulusu, A Roy
Journal of Chemical Information and Modeling 61 (2), 621-630, 2021
552021
Carbohydrate binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds (VVLB4)
KD Puri, B Gopalakrishnan, A Surolia
FEBS letters 312 (2-3), 208-212, 1992
541992
Strong and weak hydrogen bonds in protein–ligand recognition
G Bulusu, GR Desiraju
Journal of the Indian Institute of Science 100 (1), 31-41, 2020
522020
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors
AK Chakraborti, B Gopalakrishnan, ME Sobhia, A Malde
Bioorganic & medicinal chemistry letters 13 (15), 2473-2479, 2003
482003
3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors
AK Chakraborti, B Gopalakrishnan, ME Sobhia, A Malde
European journal of medicinal chemistry 38 (11-12), 975-982, 2003
442003
Unique properties of Plasmodium falciparum porphobilinogen deaminase
VA Nagaraj, R Arumugam, B Gopalakrishnan, YS Jyothsna, ...
Journal of biological chemistry 283 (1), 437-444, 2008
432008
De Novo Structure-Based Drug Design Using Deep Learning
SR Krishnan, N Bung, SR Vangala, R Srinivasan, G Bulusu, A Roy
Journal of Chemical Information and Modeling 62 (21), 5100-5109, 2021
412021
Mycobacterium tuberculosis chorismate mutase: A potential target for TB
M Khanapur, M Alvala, M Prabhakar, KS Kumar, RK Edwin, PS Saranya, ...
Bioorganic & medicinal chemistry 25 (6), 1725-1736, 2017
412017
Design of EGFR kinase inhibitors: a ligand-based approach and its confirmation with structure-based studies
A Vema, SK Panigrahi, G Rambabu, B Gopalakrishnan, J Sarma, ...
Bioorganic & medicinal chemistry 11 (21), 4643-4653, 2003
402003
A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53
A Ghosh, A Sengupta, GPK Seerapu, A Nakhi, EVVS Ramarao, N Bung, ...
Biochemical and biophysical research communications 488 (3), 562-569, 2017
392017
The system can't perform the operation now. Try again later.
Articles 1–20